ETFsSTOXX Europe 600 (Net Return) EUR
Amundi

Amundi Core Stoxx Europe 600 UCITS ETF Acc

MEUD LSEAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
319.08EUR
-0.36% · -€1.16
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
MEUDBase
Fund charges
0.07%Total expense ratio (TER)
Fund size
€22.4bnall share classes
Return 1Y
+15.6%Index +14.3%
Sharpe 3Y
1.09Index 1.04
Volatility 1Y
12.4%annualised
Holdings
611Fund holdings

Performance

Compare
  • MEUD+15.6%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
MEUD+1.7%-0.1%+7.4%+11.5%+15.6%+63.8%+56.6%
STOXX Europe 600+1.9%-1.1%+6.1%+10.8%+14.3%+62.6%+56.9%
Gap to STOXX Europe 600-0.3%+1.1%+1.3%+0.7%+1.3%+1.2%-0.3%

Risk and return

Sharpe ratio · 3Y
1.09
Above STOXX Europe 600 · 1.04
Return p.a.
+16.8%
Volatility
12.4%
Max loss
-16.2%Apr 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
MEUD
1.09
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
20.5%
Holdings
611
As of
Fund holdings
  1. 1ASML HOLDING NVNL00102732154.32%
  2. 2ROCHE HOLDING AG - GENUSSS CHFCH14990599832.26%
  3. 3NOVARTIS AG-REGCH00120052672.01%
  4. 4SHELL PLC EURGB00BP6MXD841.98%
  5. 5HSBC HOLDINGS PLCGB00054052861.97%
  6. 6ASTRAZENECA GBPGB00098952921.79%
  7. 7NESTLE SA-REGCH00388633501.71%
  8. 8SAP SE / XETRADE00071646001.56%
  9. 9SIEMENS AG-REGDE00072361011.49%
  10. 10TOTALENERGIES SE PARISFR00001202711.43%

Countries

Classified 99.7%
Largest
23.2%United Kingdom
Top 3
51.9%
Effective number
7.81 / HHI

Market cap

Weight vs holdings

20.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.